StockData
Serina Therapeutics, Inc. logo

Serina Therapeutics, Inc. (SER) stock

SERNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.35−0.01 (-1.10%)

Close on Nov 18, 2026Market cap $34.29MP/E –Yield –

Serina Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Serina Therapeutics's pe ratio was 12.2× on Apr 30, 2024.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Apr 30, 202412.2×+2.5
2023Dec 29, 20239.6×–

More Serina Therapeutics figures

See a number that looks wrong?